Here's what we'll cover
Here's what we'll cover
If you've ever searched for GLP-1 medications online, you've probably noticed how many platforms promise a fast, easy path to a prescription. A new study now confirms what many patients suspected: that ease comes at a cost, and that cost is often adequate medical oversight.
A secret shopper investigation, published in 2026, sent researchers posing as prospective patients to multiple online GLP-1 prescribing platforms. What they found should matter to anyone currently shopping for a telehealth provider.
What the Secret Shopper Study Actually Found
Researchers submitted intake requests to a range of online platforms offering GLP-1 medications, including semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro).
The findings pointed to a consistent pattern across many platforms. Prescriptions were frequently issued after minimal intake questionnaires, with little to no real-time interaction with a licensed clinician. In several cases, approvals came back within minutes, before a human could have meaningfully reviewed a complete medical profile.
Some platforms did not ask about medical history in enough depth to catch common contraindications for GLP-1 drugs. Those include a personal or family history of certain thyroid cancers, pancreatitis, or gallbladder disease. Others skipped questions about current medications that could interact with GLP-1 treatments.
Why This Matters Beyond Just "Bad Service"
This isn't a complaint about slow customer service or a clunky app. Missing key health information before prescribing a powerful medication can lead to serious adverse events. GLP-1 receptor agonists are effective, but they are not appropriate for everyone, and they require ongoing monitoring to catch side effects early.
How GLP-1 Telehealth Is Supposed to Work
Legitimate telehealth prescribing for GLP-1 medications should follow the same clinical standards as an in-person visit. That means a thorough intake process, a review of your current medications, an assessment of your BMI and weight history, and a discussion of potential risks.
The FDA has approved semaglutide (Wegovy) and tirzepatide (Zepbound) for chronic weight management in adults who meet specific clinical criteria. Meeting those criteria isn't just a checkbox. It's a clinical decision that requires real judgment.
What a Thorough GLP-1 Intake Should Include
A responsible telehealth provider should ask about:
- Your current and past diagnoses, including thyroid, kidney, and gastrointestinal conditions
- Your full medication list, including supplements
- Previous weight loss attempts and results
- Your current BMI and any related comorbidities (conditions that occur alongside obesity)
- Your goals, lifestyle, and ability to commit to monitoring and follow-up
If your intake form takes less than five minutes and you get approved the same day with no follow-up questions, that's worth pausing on.
The Risk of Compounded GLP-1 Medications
The study's findings overlap with another ongoing issue in the GLP-1 space: the rise of compounded semaglutide and compounded tirzepatide. Many of the platforms offering the quickest approvals are also prescribing compounded versions of these drugs, which are produced by third-party pharmacies rather than the original manufacturers.
Compounded medications are not FDA-approved. They may vary in concentration, sterility, and quality depending on the pharmacy. The FDA has previously issued warnings about compounded GLP-1 products and has taken enforcement actions against certain compounders.
This doesn't mean all compounded GLP-1 medications are dangerous. But if a platform is rushing through clinical oversight and also prescribing compounded versions, the combination of risks compounds too.
FDA Approval Status: Brand vs. Compounded
| Medication | Brand Name | FDA-Approved | Compounded Version Available |
|---|---|---|---|
| Semaglutide (weight loss) | Wegovy | Yes | Yes (not FDA-approved) |
| Semaglutide (diabetes) | Ozempic | Yes | Yes (not FDA-approved) |
| Tirzepatide (weight loss) | Zepbound | Yes | Yes (not FDA-approved) |
| Tirzepatide (diabetes) | Mounjaro | Yes | Yes (not FDA-approved) |
Why Platforms Cut Corners: The Business Model Problem
Understanding why this happens helps you evaluate providers more clearly.
Many online GLP-1 platforms operate on a subscription model. Their revenue depends on converting prospective patients into paying subscribers quickly. The faster they approve you, the sooner they bill you. This creates a structural tension between business efficiency and good clinical practice.
This isn't an accusation against every telehealth company. Many operate with genuine clinical rigor. But the business incentive to approve quickly is real, and the study's findings suggest it's influencing prescribing behavior at a significant number of platforms.
The platforms that do it right tend to be slower. They may ask follow-up questions. They may require lab work before issuing a prescription. They may even decline to prescribe if you don't meet clinical criteria. Those are signs of quality, not obstacles.
How to Evaluate a GLP-1 Telehealth Provider
If you're comparing platforms, here are concrete things to look for before you hand over your credit card or health history.
Green Flags: Signs of a Trustworthy Provider
- A detailed intake process that takes 15 minutes or more
- Requirement for recent lab work or willingness to order it
- A real consultation with a licensed clinician, not just a chatbot or automated form
- Clear information about what medication you're being prescribed and why
- A follow-up schedule built into the program
- Transparent pricing with no hidden fees
Red Flags: Proceed With Caution
- Approval in minutes with no follow-up
- No mention of contraindications or side effects during intake
- Prescription issued without any clinician interaction
- Compounded-only medication options with no explanation of the differences from brand-name drugs
- Heavy reliance on patient-reported information with no verification
You can compare vetted providers at Best Providers, where platforms are evaluated based on clinical standards, not just price and convenience.
What This Means for Cost and Value
There's a real temptation to choose the cheapest or fastest option, especially when brand-name GLP-1 medications can cost $900 to $1,400 per month without insurance. Compounded versions from low-oversight platforms often come in at $150 to $400 per month. The savings look significant on paper.
But consider what you're not getting. If a platform doesn't properly screen you before prescribing, it's also unlikely to monitor you effectively during treatment. Missed side effects, improper dosing, and lack of follow-up care can lead to outcomes that cost more to address than you saved on the prescription.
| Provider Type | Typical Monthly Cost | Clinician Oversight | Medication Type |
|---|---|---|---|
| Brand-name via insurance | $0 to $100 (with coverage) | High (in-person or telehealth) | FDA-approved brand |
| Brand-name via reputable telehealth | $200 to $500+ (with coupons) | High | FDA-approved brand |
| Compounded via reputable telehealth | $150 to $350 | Medium to High | Compounded (not FDA-approved) |
| Compounded via low-oversight platform | $99 to $250 | Low | Compounded (not FDA-approved) |
If cost is a primary concern, there are legitimate ways to reduce what you pay. Manufacturer savings programs, pharmacy discount cards, and GLP-1 Coupons can meaningfully lower the price of brand-name medications without sacrificing care quality.
Questions to Ask Before You Commit to Any Provider
You have every right to ask hard questions before choosing a GLP-1 telehealth platform. Here are seven worth putting to any provider you're evaluating:
- Will I speak directly with a licensed clinician before receiving a prescription?
- What medical history information do you review, and how?
- Do you require lab work, and if not, why not?
- Are you prescribing a brand-name FDA-approved medication or a compounded version?
- What follow-up is included, and how often will my progress be reviewed?
- What happens if I experience side effects? Who do I contact?
- How do you handle patients who don't meet clinical criteria?
A platform that can't or won't answer these questions clearly is telling you something important.
No waiting list. No insurance needed.
Frequently Asked Questions
Is it safe to get a GLP-1 prescription online?
It can be safe, but only if the platform follows proper clinical standards. A legitimate telehealth provider will conduct a thorough intake, review your full medical history, and schedule follow-up care. Platforms that approve prescriptions in minutes with minimal review pose real health risks.
What did the secret shopper study find about online GLP-1 prescribing?
The study found that many online platforms issued GLP-1 prescriptions after minimal clinical review, sometimes without adequate screening for contraindications or drug interactions. Some approvals came back within minutes, suggesting no meaningful clinician review occurred.
What are the contraindications for GLP-1 medications?
GLP-1 medications are generally not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. They also require caution in people with a history of pancreatitis, gallbladder disease, or severe kidney problems. A thorough clinician review should always check for these before prescribing.
Are compounded semaglutide and tirzepatide safe?
Compounded versions of semaglutide and tirzepatide are not FDA-approved, meaning they haven't gone through the same rigorous testing as brand-name versions. Quality varies between compounding pharmacies. The FDA has issued warnings about some compounded GLP-1 products. If you use a compounded medication, it's important to use a reputable, licensed 503B compounding pharmacy.
How do I know if a GLP-1 telehealth provider is legitimate?
Look for providers that require a real clinician consultation, ask for detailed medical history, conduct or request lab work, explain the differences between compounded and brand-name medications, and offer structured follow-up care. Red flags include instant approvals, no mention of side effects, and no access to a real clinician.
Can I get brand-name Wegovy or Mounjaro through telehealth?
Yes. Several reputable telehealth platforms prescribe FDA-approved brand-name semaglutide (Wegovy) and tirzepatide (Zepbound or Mounjaro), not just compounded versions. These prescriptions can sometimes be paired with manufacturer savings programs or pharmacy coupons to reduce cost.
The Bottom Line: Convenience Shouldn't Come at the Cost of Your Safety
Telehealth has genuinely expanded access to GLP-1 medications for people who might otherwise face long wait times, limited local specialists, or the logistical barriers of in-person care. That expanded access is valuable, and it has helped many people start treatments that have meaningfully improved their health.
But the secret shopper study is a reminder that not all telehealth is created equal. The fact that a prescription is easy to get does not mean it's safe, appropriate, or right for your situation. The speed of approval is not a measure of quality. In many cases, it's the opposite.
If you're currently taking a GLP-1 medication prescribed through an online platform and you're not sure whether you received adequate clinical evaluation, that's worth addressing now. A conversation with your primary care physician can help confirm you're on the right dose, that your medication is appropriate given your health history, and that you have a plan for monitoring and follow-up.
If you're still in the process of choosing a provider, take your time. Read what's required of patients before approval. Ask whether a licensed clinician reviews your intake personally. Find out what the follow-up process looks like.
You deserve more than a quick approval from an automated form. You deserve a care team that's paying attention.
Where to Go From Here
GLP-1.com has done the work of vetting providers so you don't have to start from scratch. Our Best Providers comparison tool evaluates telehealth platforms on the clinical factors that actually matter, not just price and speed.
If cost is a concern, our GLP-1 Coupons page lists current savings options for brand-name medications including Wegovy, Ozempic, and Mounjaro. Getting legitimate, well-supervised care doesn't have to be out of reach financially.
Always speak with a licensed physician before starting, stopping, or changing any medication. The right provider will make that conversation easy, not optional.